Physiologic Targets and Modes of Action for CBL0137, a Lead for Human African Trypanosomiasis Drug Development
Carlos E. Sanz-Rodríguez(University of Georgia), Kojo Mensa‐Wilmot(University of Georgia)
Cited by 5
Related Papers
A glycosylphosphatidylinositol (GPI)-negative phenotype produced in Leishmania major by GPI phospholipase C from Trypanosoma brucei: topography of two GPI pathways
|The Journal of Cell Biology|1994|64
Pseudokinase NRP1 facilitates endocytosis of transferrin in the African trypanosome
|Scientific Reports|2022|5